Deborah Rathjen - BNO BE Insider

BNO BE -- Germany Stock  

 0.91  0.00  0.00%

CEO, Managing Director, Executive Director

Dr. Deborah Rathjen, BSc, MAICD, Ph.D., is Chief Executive Officer, Managing Director and Executive Director of Bionomics Ltd. She joined Bionomics in 2000 from Peptech Limited, where she was General Manager of Business Development and Licensing. Dr Rathjen was a coinventor of Peptechs TNF technology and leader of the companys successful defence of its key TNF patents against a legal challenge by BASF. Dr Rathjen has significant experience in company building and financing, mergers and acquisitions, therapeutic product research and development, business development, licensing and commercialisation. Dr Rathjen was recognised both in Australia and internationally through awards and honours including the 2004 AusBiotech Presidents Medal, 2006 Flinders University Distinguished Alumni Award, 2009 BioSingapore Asia Pacific Biotechnology Woman Entrepreneur of the Year, 2009 Regional Finalist Ernst Young Entrepreneur of the Year, 2014 Woman Executive of the Year BioPharm Industry Awards. In 2015 Dr Rathjen was included in the Top 50 most influential Australian business women by The Australian newspaper.
    Ph.D    
Rathjen is Chairperson of the AusBiotech Board, and is a member of the Higher Education Council . In 2004 Dr. Rathjen was awarded the AusBiotech President Medal for her contribution to the Australian biotechnology industry and in 2006 received a Distinguished Alumni Award from Flinders University.

Management Efficiency

Similar Executives

Entity Summary

BNO BE (BNO) is traded on Berlin Stock Exchange in Germany. and employs 8 people.

Did you try this?

Run Focused Opportunities Now
   

Focused Opportunities

Build portfolios using our predefined set of ideas and optimize them against your investing preferences
Hide  View All  NextLaunch Focused Opportunities
Fix your portfolio
By capturing your risk tolerance and investment horizon Macroaxis technology of instant portfolio optimization will compute exactly how much risk is acceptable for your desired return expectations when you add BNO BE to your portfolio

Top Management

BNO BE Leadership Team
Stephen Birrell, CFO
Jens Mikkelsen, Executive, Ph.D
Melanie Young, CFO
Steve Lydeamore, CFO, CPA
Robert Corringham, Executive
Trevor Tappenden, Director
Alan Dunton, Director
Graeme Kaufman, Director, MBA
Peter Turner, Director
Errol Souza, Director, Ph.D
David Wilson, Director
Deborah Rathjen, CEO, Ph.D
Tony Colasin, Executive
Alan Fisher, Director
Jose Iglesias, Executive, Ph.D
Jack Moschakis, Executive
Jonathan Lim, Director

Stock Performance

BNO BE Performance Indicators